Many at high cardiovascular risk still not on statins

May 13, 2014
Many at high cardiovascular risk still not on statins

(HealthDay)—Many individuals at high risk for cardiovascular events, such as those with coronary artery disease, diabetes, or both, are not receiving statins, according to research published in the May/June issue of the Annals of Family Medicine.

Michael Edward Johansen, M.D., of The Ohio State University in Columbus, and colleagues analyzed data for a nationally representative sample of 16,712 individuals in the United States, aged 30 to 79 years, to assess the association between statin use and cardiovascular risk. Those who reported filling two or more statin prescriptions were classified as statin users.

The researchers found that, overall, 58.2 percent of individuals with coronary artery disease (95 percent confidence interval [CI], 54.6 to 61.7 percent) and 52.0 percent of those with diabetes who were older than 40 years (95 percent CI, 49.4 to 54.6 percent) were statin users. After multivariable adjustment, the likelihood of being a statin user was significantly higher among individuals with both hyperlipidemia and coronary artery disease (odds ratio [OR], 0.44; 95 percent CI, 0.40 to 0.48) or hyperlipidemia only (OR, 0.32; 95 percent CI, 0.30 to 0.33) than among those with only (OR, 0.11; 95 percent CI, 0.07 to 0.15). A similar pattern was observed among individuals with diabetes.

"Recently released guidelines from the American College of Cardiology and the American Heart Association offer an opportunity to improve statin use by focusing on instead of lipid levels," the authors write.

Explore further: Vegetarian black adventists have lower cardiovascular risk

More information: Abstract
Full Text

Related Stories

Interarm BP difference may up cardiac risk in diabetes

April 3, 2014

(HealthDay)—Interarm differences in systolic blood pressure (BP) in patients with diabetes may be associated with an increased risk of cardiovascular morbidity and mortality, according to research published online on March ...

Clopidogrel after MI less effective in diabetes patients

September 5, 2012

(HealthDay)—Clopidogrel therapy following a heart attack does less to reduce the risk of death in patients with diabetes than in those without diabetes, according to a study published in the Sept. 5 issue of the Journal ...

Recommended for you

Macrophages shown to be essential to a healthy heart rhythm

April 20, 2017

A Massachusetts General Hospital (MGH)-led research team has identified a surprising new role for macrophages, the white blood cells primarily known for removing pathogens, cellular debris and other unwanted materials. In ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.